UT Health San Antonio researcher wins coveted National Cancer Institute award

September 17, 2019

Dr. Sung is the first faculty member in UT Health San Antonio history to capture this prestigious NCI award, which is bestowed only upon researchers with august track records.

Novel therapy developed for inherited breast cancer

September 10, 2019

UT Health San Antonio researchers have discovered a novel way to kill cancers that are caused by an inherited mutation in BRCA1, the type of cancer for which actress Angelina Jolie had preventive double mastectomy and reconstructive surgery in 2013. “This represents a new treatment for inherited breast and ovarian cancer, which are higher in […]

FDA approves new drug to treat a rare blood cancer

September 10, 2019

The U.S. Food and Drug Administration recently approved the first new medication in nearly a decade for patients with myelofibrosis, a rare blood cancer. Ruben Mesa, M.D., FACP, director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was part of the international research team that led development of […]

Women in Medicine Month

September 4, 2019

September is Women in Medicine Month. Read about the achievements and talents of some of UT Health San Antonio’s women faculty in the first in a series of newsletters. View the newsletter

UT Health scientist continues study of children’s cancer using new grant to predict drug responses from genomic data

August 28, 2019

The largest award, $892,157, went to Yidong Chen, Ph.D., a professor of population health sciences in the Joe R. and Teresa Lozano Long School of Medicine.

New division chief named for hematology/medical oncology

August 20, 2019

Daruka Mahadevan, M.D., Ph.D., will also lead the hematology and medical oncology service line within the Mays Cancer Center.